Andrew Crenshaw | April 22, 2019

Adapting Clinical Trial Best Practices to a Complex Global CDx Landscape

World CDx Europe 2019
This presentation reviews the central laboratory’s role for executing companion diagnostics globally, the requirements for effective collaboration between pharmaceutical and IVD companies regarding biomarkers. It focuses on key attributes required for complex oncology trials. Q2 Solutions presented this lecture during the World CB and CDx Europe 2019 conference.

Download this presentation to learn more.

Related Services:
Companion Diagnostic Development: Current trends and recommendations

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Clinical Trials Laboratories in the Immuno-Oncology Setting

Increased demands lead to increased opportunities

Read More